Inflammation & Immune Activity Panel
Comprehensive inflammation and immune activity panel including hs-CRP, Sed Rate, ferritin, fibrinogen activity (Clauss), and complete blood count with differential and platelets. Designed to assess systemic inflammation, immune response, coagulation patterns, and iron status for a clearer understanding of inflammatory health.
- $119
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Absolute Band Neutrophils (Only Reported If Detected)
Absolute Basophils
Absolute Blasts (Only Reported If Detected)
Absolute Eosinophils
Absolute Lymphocytes
Absolute Metamyelocytes (Only Reported If Detected)
Absolute Monocytes
Absolute Myelocytes (Only Reported If Detected)
Absolute Neutrophils
Absolute Nucleated Rbc (Only Reported If Detected)
Absolute Promyelocytes (Only Reported If Detected)
Band Neutrophils (Only Reported If Detected)
Basophils
Blasts (Only Reported If Detected)
Eosinophils
Hematocrit
Hemoglobin
Lymphocytes
MCH
MCHC
MCV
Metamyelocytes (Only Reported If Detected)
Monocytes
MPV
Myelocytes (Only Reported If Detected)
Neutrophils
Nucleated Rbc (Only Reported If Detected)
Platelet Count
Promyelocytes (Only Reported If Detected)
RDW
Reactive Lymphocytes (Only Reported If Detected)
Red Blood Cell Count
White Blood Cell Count
Ferritin
Also known as: Factor I, Fibrinogen, Fibrinogen Activity Clauss
Fibrinogen Activity,
Also known as: C-Reactive Protein, Cardio CRP, Cardio hs-CRP, CRP, High Sensitivity CRP, High-sensitivity C-reactive Protein, High-sensitivity CRP, Highly Sensitive CRP, hsCRP, Ultra-sensitive CRP
Hs Crp
Also known as: ESR, SED RATE, Sed Rate by Modified Westergren ESR
Sed Rate By Modified
The Inflammation & Immune Activity Panel panel contains 5 tests with 37 biomarkers .
A Comprehensive Evaluation of Systemic Inflammation and Immune Response
The Inflammation & Immune Activity Panel is a focused laboratory assessment designed to evaluate markers associated with systemic inflammation, immune activation, and clotting dynamics. Inflammation is a fundamental biological process that plays a central role in immune defense, tissue repair, and response to injury. However, persistent or excessive inflammation may be associated with a wide range of acute and chronic health conditions.
This panel combines High-Sensitivity C-Reactive Protein (hs-CRP), Erythrocyte Sedimentation Rate (Sed Rate or ESR), Ferritin, Fibrinogen Activity (Clauss method), and a Complete Blood Count (CBC) with Differential and Platelets. Together, these tests provide a multidimensional view of inflammatory signaling, immune cell activity, iron storage status, and coagulation function.
Because inflammation can present with nonspecific symptoms—such as fatigue, joint discomfort, low-grade fevers, or general malaise—laboratory testing can offer valuable objective insight. This panel is designed to support evaluation of both acute and chronic inflammatory processes by examining complementary biomarkers that reflect different pathways within the immune and inflammatory response.
Unlike a single inflammatory marker, this panel integrates acute-phase reactants, clotting proteins, and cellular immune components into one cohesive profile. The result is a clinically meaningful overview of immune activity that may assist healthcare providers in identifying patterns, guiding further evaluation, and monitoring changes over time.
When and Why Someone Would Order This Panel
Evaluation of Persistent or Unexplained Inflammatory Symptoms
Individuals may consider the Inflammation & Immune Activity Panel when experiencing ongoing symptoms that suggest possible inflammatory or immune system involvement. These symptoms may include fatigue, joint discomfort, muscle aches, low-grade fever, or other signs of systemic inflammation. Because these symptoms are often nonspecific, laboratory evaluation can help provide clarity.
This panel may be appropriate for individuals who:
-
Have unexplained inflammatory symptoms
-
Are being evaluated for autoimmune or rheumatologic conditions
-
Have chronic inflammatory disorders
-
Are monitoring known inflammatory markers
-
Have a family history of inflammatory or immune-related diseases
Monitoring Autoimmune or Rheumatologic Conditions
Conditions such as rheumatoid arthritis, systemic lupus erythematosus, and other autoimmune disorders often involve elevated inflammatory markers. Tests such as hs-CRP and Sed Rate are commonly used to monitor inflammatory activity in these conditions. Fibrinogen and ferritin may also reflect acute-phase responses in systemic inflammation.
Cardiometabolic and Vascular Considerations
Chronic low-grade inflammation has been associated with cardiometabolic conditions. Elevated hs-CRP levels, in particular, have been studied in the context of cardiovascular risk assessment. While this panel does not replace cardiovascular-specific testing, it provides insight into inflammatory pathways that may influence vascular health.
Evaluation of Iron and Immune Interaction
Ferritin is both an iron storage protein and an acute-phase reactant. Elevated ferritin levels may reflect inflammation, while low levels may indicate iron deficiency. Assessing ferritin alongside other inflammatory markers helps provide a more comprehensive clinical picture.
Overall, this panel may be ordered as part of a broader evaluation of systemic inflammation, immune activation, or chronic disease monitoring.
What Does the Panel Measure?
High-Sensitivity C-Reactive Protein (hs-CRP)
hs-CRP is a sensitive marker of systemic inflammation produced by the liver in response to inflammatory signaling. It is commonly used to detect low-grade inflammation and may be elevated in infections, autoimmune conditions, and chronic inflammatory states.
Erythrocyte Sedimentation Rate (Sed Rate or ESR)
The Sed Rate measures how quickly red blood cells settle in a test tube over a defined period. Faster sedimentation can indicate the presence of inflammation. ESR is a traditional marker used in the evaluation of inflammatory and rheumatologic disorders.
Ferritin
Ferritin reflects stored iron levels in the body. It also functions as an acute-phase reactant and may increase during inflammatory states. Interpreting ferritin alongside other inflammatory markers helps differentiate iron deficiency from inflammation-related changes.
Fibrinogen Activity (Clauss Method)
Fibrinogen is a clotting protein produced by the liver. It plays a role in blood coagulation and is also considered an acute-phase reactant. Elevated fibrinogen levels may be associated with inflammatory processes and altered coagulation dynamics.
Complete Blood Count (CBC) with Differential and Platelets
The CBC evaluates red blood cells, white blood cells, hemoglobin, hematocrit, and platelet counts. The differential provides a breakdown of white blood cell subtypes, which may shift during infections, inflammatory responses, or immune activation. Platelet levels may also increase in inflammatory states.
Together, these biomarkers provide complementary insights into immune system activity, inflammatory burden, and hematologic patterns.
How Patients and Healthcare Providers Use the Results
Identifying Active Inflammation
Elevated hs-CRP, Sed Rate, fibrinogen, or ferritin levels may suggest the presence of active inflammation. When interpreted together, these markers can help determine whether inflammation is acute, chronic, or potentially linked to another underlying process.
Supporting Evaluation of Autoimmune and Rheumatologic Conditions
Healthcare providers often use inflammatory markers as part of the evaluation for conditions such as rheumatoid arthritis, polymyalgia rheumatica, systemic lupus erythematosus, and other connective tissue disorders. Changes in these markers over time may help assess disease activity or response to treatment.
Monitoring Infection or Acute Illness
Infections can trigger elevations in inflammatory markers and white blood cell counts. The CBC differential may show patterns consistent with bacterial or viral immune responses, providing additional context.
Assessing Iron Status in Inflammatory Context
Ferritin levels may rise in response to inflammation even when iron stores are adequate. By reviewing ferritin alongside hs-CRP and Sed Rate, healthcare providers can better interpret iron status within the context of systemic inflammation.
Evaluating Coagulation-Related Inflammatory Changes
Fibrinogen activity may increase in inflammatory states and can provide additional information about clotting dynamics. This may be clinically relevant in certain inflammatory or cardiovascular risk assessments.
Through integrated interpretation, this panel supports informed clinical decision-making and longitudinal monitoring of inflammatory patterns.
A Structured Approach to Understanding Inflammation and Immune Activity
The Inflammation & Immune Activity Panel offers a comprehensive evaluation of key biomarkers associated with systemic inflammation and immune response. By combining acute-phase reactants, coagulation markers, iron storage assessment, and detailed blood cell analysis, this panel provides a broad yet focused overview of inflammatory activity.
Inflammation plays a central role in many health conditions, from autoimmune disorders to cardiometabolic disease. Objective laboratory data can help clarify whether inflammatory processes are present and how they evolve over time.
This panel supports thoughtful, evidence-based evaluation by integrating multiple complementary markers into one cohesive assessment. When interpreted alongside clinical findings, it helps provide a clearer understanding of immune system activity and inflammatory burden, guiding informed healthcare discussions and long-term monitoring strategies grounded in measurable data.